Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-05-19

Study Completion Date

2035-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

NCT00897806

Ovarian Cancer Peritoneal Cavity Cancer

TERMINATED

Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer

NCT01096394

Ovarian Cancer

COMPLETED

Prognostic Value of MRD Detection in CA125 Non-sensitive Ovarian Cancer Patients

NCT06182917

Ovarian Cancer

RECRUITING

Elizabeth Registry for Low Grade Ovarian Cancer

NCT00345709

Ovarian Cancer

COMPLETED

Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer

NCT00039559

Ovarian Cancer

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To collect, both prospectively and retrospectively, data on disease characterization, treatment, and outcomes for approximately 1600 female patients with low-grade ovarian and peritoneal tumors.

II. To organize clinical information in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome.

III. To have a single data repository, kept on a secure platform that will integrate clinical information and research findings and serve as a secure archive for future research.

SECONDARY OBJECTIVE:

I. To obtain and store human tumor samples in the form of blocks or slides for the purpose of establishing a tumor bank.

OUTLINE:

Patients' medical records are reviewed for retrospective and prospective data collection. Patients may also have residual tissue samples collected and stored.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Grade Ovarian Serous Adenocarcinoma Malignant Ovarian Neoplasm Ovarian Carcinoma Primary Peritoneal Carcinoma Primary Peritoneal Low Grade Serous Adenocarcinoma Psammocarcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational (electronic health record review)

Patients' medical records are reviewed for retrospective and prospective data collection. Patients may also have residual tissue samples collected and stored.

Biospecimen Collection

Intervention Type PROCEDURE

Patients' residual tissue samples are collected

Electronic Health Record Review

Intervention Type OTHER

Medical records are reviewed

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Biospecimen Collection

Patients' residual tissue samples are collected

Intervention Type PROCEDURE

Electronic Health Record Review

Medical records are reviewed

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:

* Ovarian tumor of low malignant potential
* Low-grade serous carcinoma of the ovary
* Primary peritoneal tumor of low malignant potential
* Low-grade serous carcinoma of the peritoneum
* Psammocarcinoma

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No